Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients

cnbc.com/2025/08/18/novo-nordisk-offers-diabetes-drug-ozempic-for-steep-cash-discount.html

Novo Nordisk on Monday said it now offers cash-paying U.S. patients its blockbuster diabetes treatment Ozempic for less than half its monthly list price, as drugmakers face mounting political pressure to lower prices in the country.
Patients can pay $499 in cash per month for three dose…

This story appeared on cnbc.com, 2025-08-18 13:38:26.864000.
The Entire Business World on a Single Page. Free to Use →